Form 8-K - Current report:
SEC Accession No. 0001193125-24-235275
Filing Date
2024-10-09
Accepted
2024-10-09 17:13:00
Documents
20
Period of Report
2024-10-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d857933d8k.htm   iXBRL 8-K 31587
2 EX-1.1 d857933dex11.htm EX-1.1 205871
3 EX-5.1 d857933dex51.htm EX-5.1 11502
4 EX-99.1 d857933dex991.htm EX-99.1 10494
5 EX-99.2 d857933dex992.htm EX-99.2 10982
9 GRAPHIC g857933g1009112207236.jpg GRAPHIC 3361
10 GRAPHIC g857933g1009112325165.jpg GRAPHIC 3356
11 GRAPHIC g857933g1009112557891.jpg GRAPHIC 2428
  Complete submission text file 0001193125-24-235275.txt   474483

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crnx-20241008.xsd EX-101.SCH 2857
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20241008_lab.xml EX-101.LAB 17236
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20241008_pre.xml EX-101.PRE 10817
22 EXTRACTED XBRL INSTANCE DOCUMENT d857933d8k_htm.xml XML 3510
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 241363302
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)